Qsam Biosciences Analysis
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
Qsam Biosciences is overvalued with Real Value of 4.11 and Hype Value of 4.49. The main objective of Qsam Biosciences otc analysis is to determine its intrinsic value, which is an estimate of what Qsam Biosciences is worth, separate from its market price. There are two main types of Qsam Biosciences' stock analysis: fundamental analysis and technical analysis.
The Qsam Biosciences otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Qsam |
Qsam OTC Stock Analysis Notes
About 52.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.69. Qsam Biosciences last dividend was issued on the 10th of September 2020. The entity had 1:2000 split on the 3rd of May 2024. QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.The quote for Qsam Biosciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Qsam Biosciences contact Douglas Baum at 512 343 4558 or learn more at https://qsambio.com.Qsam Biosciences Investment Alerts
| Qsam Biosciences is not yet fully synchronised with the market data | |
| Qsam Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Qsam Biosciences currently holds 7.5 K in liabilities with Debt to Equity (D/E) ratio of 2.08, implying the company greatly relies on financing operations through barrowing. Qsam Biosciences has a current ratio of 0.23, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qsam Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Qsam Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qsam Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qsam to invest in growth at high rates of return. When we think about Qsam Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.39 M) with profit before overhead, payroll, taxes, and interest of 916.67 K. | |
| Qsam Biosciences currently holds about 429.35 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 52.0% of Qsam Biosciences outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating ... |
Qsam Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 73.79 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Qsam Biosciences's market, we take the total number of its shares issued and multiply it by Qsam Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Qsam Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Qsam Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Qsam Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Qsam Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
King Adam over six months ago Disposition of tradable shares by King Adam of Qsam Biosciences at 9.62 subject to Rule 16b-3 | ||
Link Jr Charles J over six months ago Qsam Biosciences exotic insider transaction detected | ||
Christopher Nelson over six months ago Conversion by Christopher Nelson of 8683 shares of Qsam Biosciences | ||
Piazza C Richard over six months ago Qsam Biosciences exotic insider transaction detected | ||
King Adam over a year ago Acquisition by King Adam of 20910 shares of Qsam Biosciences subject to Rule 16b-3 | ||
Link Jr Charles J over a year ago Acquisition by Link Jr Charles J of 10455 shares of Qsam Biosciences subject to Rule 16b-3 |
Qsam Biosciences Outstanding Bonds
Qsam Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Qsam Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Qsam bonds can be classified according to their maturity, which is the date when Qsam Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| QORVO INC 3375 Corp BondUS74736KAJ07 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| QORVO INC 4375 Corp BondUS74736KAH41 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Qsam Biosciences Predictive Daily Indicators
Qsam Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Qsam Biosciences otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Qsam OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Qsam Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Qsam shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Qsam Biosciences. By using and applying Qsam OTC Stock analysis, traders can create a robust methodology for identifying Qsam entry and exit points for their positions.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Qsam Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |